Sygnature Discovery and Viramatix announce anti-viral drug discovery strategic alliance

Nottingham, UK and Kuala Lumpur, Malaysia; 5th October 2016 – Sygnature Discovery Limited, the UK’s largest independent provider of integrated drug discovery resources and expertise, and Viramatix Sdn. Bhd., a biopharmaceutical company involved in the discovery of peptide based anti-viral therapeutics, today announced their ongoing collaboration on innovative anti-influenza therapeutics. Influenza virus infection remains a […]

The Corona sculpture starts to take shape on the new ‘Discovery’ building

Sygnature Discovery today saw the start of the Brise Soleil installation on the front of the new £30m ‘Discovery’ building. which will reduce the risk of the building overheating. The sculpture known as Corona forms a curtain of metal tubes 17 metres high across the front of the building which are linked to NASA satellites […]

Sygnature are exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1

Drug Discovery 2016 will bring together 1000 delegates and 50 world-class speakers from academia and industry, each representing critical areas in drug discovery. Scientific Sessions: Innovations in Chemistry Oncology & Immunology Innovations in Predictive & Translational Models Assay Development, Screening & Emerging Technologies Coming Closer to the Patient – Cells & Genes in Therapy & […]

Sygnature Discovery’s drug discovery capabilities enhanced by acquisition of BMG LABTECH PHERAstar® FSX

July 20th 2016 – Nottingham, UK – Sygnature Discovery Limited, the UK’s largest independent provider of integrated drug discovery resource and expertise, today announced the addition of the BMG LABTECH PHERAstar® FSX into its portfolio of advanced in vitro screening capabilities. In order to maximise assay performance during drug discovery projects, Sygnature is striving to […]

Sygnature Discovery invests in further new technologies thanks to £190K grant from the N2 Business Growth Fund

15th July 2016 – Nottingham, UK – Sygnature Discovery is set for further growth after receiving a £190,000 grant from the N2 Business Growth Fund. Sygnature, which employs over 150 staff and already has 8 laboratories in its existing facilities in BioCity Nottingham, is set to expand further by taking space in the new £30m […]

Page 2 of 1012345...10...Last »
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.